Rallybio Corporation

NASDAQ:RLYB

0.5366 (USD) • At close August 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Assets:
Current Assets:
Cash & Cash Equivalents 13.90324.49456.958175.334140.23319.458
Short Term Investments 51.60885.435112.036000
Cash and Short Term Investments 65.511109.929168.994175.334140.23319.458
Net Receivables 000000
Inventory 000000
Other Current Assets 2.334.8610.5025.5351.0281.462
Total Current Assets 67.841114.789179.496180.869141.26120.92
Non-Current Assets:
Property, Plant & Equipment, Net 0.2670.5920.9090.5110.2870.199
Goodwill 000000
Intangible Assets 000000
Goodwill and Intangible Assets 000000
Long Term Investments 00.2390.030.8050.310.488
Tax Assets 000000
Other Non-Current Assets 000000
Total Non-Current Assets 0.2670.8310.9391.3160.5970.687
Total Assets 68.108115.62180.435182.185141.85821.607
Liabilities & Equity:
Current Liabilities:
Account Payables 0.2780.9761.1140.6031.5790.857
Short Term Debt 0.3080.4380.362000
Tax Payables 000000
Deferred Revenue 0.84800000
Other Current Liabilities 4.8087.8499.2685.9484.2642.949
Total Current Liabilities 6.2429.26310.7446.5515.8433.806
Non-Current Liabilities:
Long Term Debt 00.3460.748000
Deferred Revenue Non-Current 0.21200000
Deferred Tax Liabilities Non-Current 000000
Other Non-Current Liabilities 0-0.173-0.3740.0320.01238.082
Total Non-Current Liabilities 0.2120.1730.3740.032182.03938.082
Total Liabilities 6.4549.43611.1186.5835.85541.888
Equity:
Preferred Stock 0000182.02737.141
Common Stock 0.0040.0040.0040.0030.0020.286
Retained Earnings -293.02-235.245-160.681-94.027-47.014-20.567
Accumulated Other Comprehensive Income/Loss 0.0680.015-0.2140-230.031-57.994
Other Total Stockholders Equity 354.602341.41330.208269.626183.01541.134
Total Shareholders Equity 61.654106.184169.317175.602136.003-20.567
Total Equity 61.654106.184169.317175.602136.003-20.567
Total Liabilities & Shareholders Equity 68.108115.62180.435182.185141.85841.888